04/09/2015 08:26:21 Free Membership Login

   

Array

Visual Financials
Company Name: Array BioPharma Inc
Ticker Symbol: ARRY
CIK Number: 0001100412
WWW Address: http://www.arraybiopharma.com
CEO: Ron Squarer
No. of Employees: 198
Common Issue Type: CS
Business Description:Array BioPharma, Inc., is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 5.77 Unchanged 0.0 5.6 6.4  6.01 5.76 400
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 820.3 142.2 0.00 0.07 0.00 83.2 0.0 8.59 - 2.98
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close5.77$
PE Ratio - LTM83.2
Market Capitalisation820.3mil
Latest Shares Outstanding142.2mil
Earnings pS (EPS)0.07$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee332,750$
Effective Tax Rate0.0%
Float103.1mil
Float as % of Shares Outstanding0.8%
Foreign Sales9mil
Domestic Sales43mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue1.00%
Gross Profit Margin14.5%
EBITDA Margin44.9%
Pre-Tax Profit Margin18.0%
Assets Turnover30.8%
Return on Assets (ROA)5.6%
Return on Equity (ROE)110.7%
Return on Capital Invested (ROCI)17.1%
Current Ratio4.5
Leverage Ratio (Assets/Equity)4.6
Interest Cover1.9
Total Debt/Equity (Gearing Ratio)2.52
LT Debt/Total Capital72.0%
Working Capital pS1.05$
Cash pS0.00$
Book-Value pS0.30$
Tangible Book-Value pS0.30$
Cash Flow pS-0.04$
Free Cash Flow pS-0.06$
KEY FIGURES (LTM): Price info
Price/Book Ratio19.80
Price/Tangible Book Ratio0.00
Price/Cash Flow-144.9
Price/Free Cash Flow-101.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.941,763,1196,363,286
4 Weeks6.215.135.782.991,568,85932,946,054
13 Weeks8.045.137.65-22.2-151,563,046101,598,005
26 Weeks8.595.138.24-27.7-211,648,030212,595,905
52 Weeks8.592.983.7160.4632,035,657519,092,686
YTD8.594.19-23.2282,144,836368,911,859
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
5.855.696.237.146.600.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-0.010.1-0.15
Income0.0
Dividend0.0
Capital SpendingNA
R&D-8.13NA-9.51
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-31.5-47.918.4
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.18-0.080.69
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio74.98
Current Ratio4.5
Quick Ratio (Acid Test)4.4
Liquidity Ratio (Cash)5.52
Receivables Turnover8.8
Average Collection Period41
Working Capital/Equity348.4
Working Capital pS1.05
Cash-Flow pS-0.04
Free Cash-Flow pS-0.06
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio4.85
Financial Leverage Ratio (Assets/Equity)2.5
Debt Ratio54.1
Total Debt/Equity (Gearing Ratio)2.52
LT Debt/Equity2.52
LT Debt/Capital Invested75.5
LT Debt/Total Liabilities100.0
Interest Cover1.9
Interest/Capital Invested6.58
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio4.26
Current P/E Ratio - LTM83.20
Enterprise Value (EV)/EBITDA32.85
Enterprise Value (EV)/Free Cash Flow-79.81
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM19.80
Price/Cash Flow Ratio-144.9
Price/Free Cash Flow Ratio - LTM-101.0
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio129.9
5-Y Low P/E Ratio23.9
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E17
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS1.04
Current Liabilities pS0.41
Tangible Book Value pS - LTM0.30
Book Value pS - LTM0.30
Capital Invested pS1.05
Cash pS - LTM0.00
Cash Flow pS - LTM-0.04
Free Cash Flow pS - LTM-0.06
Earnings pS (EPS)0.07
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-15.99
Free Cash Flow Margin 5YEAR AVG-91.30
Net Profit Margin-0.2
Net Profit Margin - 5YEAR AVRG.-0.8
Equity Productivity1.22
Return on Equity (ROE)1.1
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity0.35
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.30
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.-0.4
Gross Profit Margin14.5
Gross Profit Margin - 5YEAR AVRG.0.4
EBITDA Margin - LTM44.9
EBIT Margin - LTM37.8
Pre-Tax Profit Margin-0.8
Pre-Tax Profit Margin - 5YEAR AVRG.-0.8
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle152,856
Revenue per Employee332,750
Net Income per Employee60,058
Average Collection Period152,856
Receivables Turnover8.8
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales8.80
Assets/Revenue3.33
Net Working Capital Turnover0.35
Fixed Assets Turnover7.25
Total Assets Turnover0.3
Revenue per $ Cash0.93
Revenue per $ Plant10.28
Revenue per $ Common Equity1.22
Revenue per $ Capital Invested0.35
Selling, General & Adm/tive (SG&A) as % of Revenue60.6
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue104.9
R&D Expense as % of Revenue - 5YEAR AVRG.104.9

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq arry150904 08:26